Biogen, Eisai Get FDA Nod for Leqembi IV Maintenance Dosing
Biogen and Eisai have won Food and Drug Administration approval of an intravenous maintenance dosing of their Leqembi drug for early Alzheimer's disease. The companies late Sunday said the FDA approved the maintenance dosing of once every four weeks after 18 months of the initiation phase of once every two weeks.
The post 3 Furnace Maintenance Tips Recommended by HVAC Experts To Save You Money appeared first on Real Estate News & ...
The Indiana Department of Transportation (INDOT) has announced that starting on January 27, crews will be closing State Road ...
For organizations considering the adoption of scalable AI for demand forecasting, it’s essential to approach implementation ...
Midwest winters take a toll on commercial buildings – here are 5 essential strategies for protecting your commercial property ...
Convenience has become a priority for consumers. From streaming services to meal kits, subscription models have ...
I-44 westbound in Laclede County will have lane closures for maintenance from Jan 26, 6 p.m. to Jan 27, 3 p.m.
When it comes to safeguarding the community from the destructive power of heavy rains and flooding, Woodlands Water is taking ...
The National Audit Office Ministers has also warned ministers that allowing the waiting list of repairs to linger is a ‘false ...
MoDOT announces maintenance in the Kansas City area from Jan 27-31, weather permitting, impacting several routes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback